Acute (subacute) subdural hematoma
Alternative names:
acute/subacute subdural hematoma; acute/subacute subdural
hemorrhage; epidural hematoma
Treatment:
Acute/subacute subdural
hematoma is an emergency condition!
Treatment goals include lifesaving measures, control of symptoms,
and minimizing or preventing permanent brain damage. Lifesaving
measures may include support of breathing and/or circulation.
Medications prescribed vary according to the type and severity
of symptoms and the extent of brain damage that occurs. Corticosteroid
medications such as dexamethasone may be used to reduce inflammation
and swelling of the brain
(see corticosteroids - oral). Diuretics may also be used to
reduce swelling. Anticonvulsant medications such as phenytoin
may be used to control or prevent seizures.
Emergency or urgent surgery may be required to reduce pressure
within the brain. This may involve drilling a small hole in
the skull to relieve pressure and allow drainage of the hematoma.
Large hematomas or solid
blood clots may need to be removed through a larger opening
in the skull (craniotomy).
Expectations (prognosis):
Acute subdural hematoma
progresses rapidly. The condition has a high death rate, even
with prompt treatment because of uncontrollable rapid increase
in intracranial pressure.
Subacute subdural hematoma may result in death or in permanent
brain damage if untreated or, in some cases, even if treated.
Symptoms such as seizures
may persist for several months after treatment. Seizures may
begin as late as 2 years after the injury.
In adults, most recovery occurs in the first 6 months, with
some improvement over approximately 2 years. Children usually
recover more quickly and completely than adults. Incomplete
recovery is the result of permanent brain damage.
Complications:
Calling your health care provider:
Go to the emergency room or call the local emergency number
(such as 911) if symptoms of subdural hematoma occur!
Emergency symptoms (that may indicate complications) include:
Update Date: 10/08/99
Updated by: adam.com editorial
|